Complement activation constitutes another key early inflammatory event in glaucoma. The complement system represents a central component of the innate neuroimmune response. Neuroimmune activation is not only confined to the eye: glial reactivity has been demonstrated along the retrobulbar optic nerve and in central visual structures, including the lateral geniculate nucleus, superior colliculus, and visual cortex.
In glaucoma, the classical pathway appears particularly relevant to early synaptic and dendritic injury. Elevated complement levels are detected in glaucomatous retinas, particularly at the optic nerve head (ONH) and inner retinal layers. Activation of retinal astrocytes correlates with increased C1q expression in retinal ganglion cells (RGCs).
C1q acts as a pattern-recognition molecule that labels stressed synapses, dendrites, and damaged cellular elements for removal. C1q expression is increased in ONH microglia before overt axonal degeneration in experimental glaucoma, while C1q deposition has also been detected within RGC dendrites in experimental models, non-human primates, and human glaucomatous retinas. This reactivation of a developmental synaptic-pruning pathway may cause inappropriate microglial elimination of otherwise salvageable RGC synapses.
In a genetic model of glaucoma, Shinozaki et al. reported that elevated IOP was accompanied by retinal C1q upregulation and RGC apoptosis. [Shinozaki Y,Kashiwagi K, Koizumi S. Astrocyte immune functions and glaucoma. Int J Mol Sci. (2023) 24:2747.] RGCs can sense damage and activate C1, triggering a cascade that activates C3 and C5 and recruits immune cells to the injury site. In a neonatal hyperoxia model, activated microglia engulfed endothelial cell fragments during retinal vessel regression, while partial microglial depletion attenuated early vascular regression and endothelial apoptosis. [Xu, Z.; Ma, Y.; Li, J.; Zhuang, J.; Liu, Y.; Lin, Z.; Liu, B.; Zhu, Z.; Chen, Z.; Wei, X.; et al. Microglial phagocytosis involves hyperoxia-induced vessel regression in the neonatal retina. Vis. Neurosci. 2025, 42, e004.]
Importantly, the role of C3 in glaucoma appears to be context dependent, showing a duality between early neuroprotection and late-stage neurotoxicity. Complement factors have dual roles in glaucoma. Early C3 activity may support protective astrocytic responses, while excessive or prolonged C3 activation and C3a receptor signaling can promote microglial recruitment and optic nerve degeneration.
Membrane attack complexes (MACs) accumulate in the ONH and RGCs, and MAC inhibition reduces RGC apoptosis. Recent evidence suggests that in the early phase of disease, astrocyte-derived C3 can signal through the epidermal growth factor receptor (EGFR) pathway, promoting astrocytic survival responses and metabolic support to stressed axons. This transient EGFR–C3 interaction may act as a compensatory mechanism, particularly under acute intraocular pressure (IOP) elevation, to preserve tissue integrity. Formation of C5b–9 may directly injure RGCs through membrane lysis; even at sublytic concentrations, MAC can stimulate intracellular Ca2+ signaling and further inflammatory activation. Increased deposition of C1q, C3, C5, and MAC has been reported in experimental and human glaucoma, including C5b–9 deposition on RGCs.
However, with sustained or chronic activation, persistent C3 cleavage leads to excessive production of downstream complement fragments (C3b, C5b-9) and ultimately the formation of MAC. MAC deposition on RGC somas and axons contributes to neurodegeneration by inducing membrane pore formation and triggering inflammatory cell recruitment.
Ischemia-reperfusion increases retinal complement expression and deposition, while C3 knockout reduces optic nerve damage and increases RGC survival.
Reactive microglia and astrocytes up-regulate major histocompatibility complex molecules, cytokines, chemokines, adhesion molecules, and antigen-presentation pathways. Concurrent dysfunction of astrocytes and vascular endothelial cells may increase blood–retinal barrier permeability, thereby creating a permissive environment for peripheral immune-cell trafficking. CCL2/CCR2 chemokine axis promotes transendothelial recruitment of circulating monocytes into the ONH and retina. These monocyte-derived macrophages may amplify local inflammation in early glaucoma through additional secretion of TNF-α, IL-1β, IL-6, and complement components.
Enucleated eyes from patients with advanced glaucoma show increased IBA1 immunoreactivity, reflecting microglial or macrophage activation, together with marked GFAP-positive astrocytic and Müller-cell gliosis in the retina and ONH. These findings validate the impression that neuroinflammation plays a central role in glaucomatous neurodegeneration.




No comments:
Post a Comment